In this study, we present preliminary data comparing the diagnostic performance of multiphasic contrast-enhanced CT with contrast enhanced MRI using a liver specific gadolinium based contrast agent (GBCA), gadoxetic acid (Gd-EOB-DTPA) and extracellular (EC) GBCAs, using explant pathologic data as the reference. We also assessed the added value of delayed hepatobiliary phase (HBP) imaging and DWI in HCC detection. Our data suggests that CT and MRI have similar overall sensitivities for HCC detection and that the addition of DWI and HBP improved HCC detection when using Gd-EOB-DTPA.
This abstract and the presentation materials are available to members only; a login is required.